how long does an unopened vial of tirzepatide last Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide — Research Peptide (Lyophilised,
Description
Tirzepatide is one of the GIP/GLP-1 dual-agonist therapies at Cosmetic Injectables Center Medspa in Sherman Oaks for adult patients meeting clinical criteria for chronic weight management or related metabolic conditions
Since microdose volumes are small, a single vial may last several weeks
The SURPASS-CVOT trial (estimated completion 2024) is evaluating long-term cardiovascular and other safety outcomes, including pancreatitis, in patients taking tirzepatide for up to 5 years
Typically, insurers require the patient to have a diagnosis of chronic migraines, defined by the International Headache Society as having at least 15 headache days per month for over three months
/patch_f/7224042 3
